Thallium-201 imaging in the assessment of tumor response to anti-tumor treatments.

The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR) Pub Date : 2003-03-01

F Berk, H Demir, C Aktolun

引用次数: 0

Abstract

The advantages and limitations of (201)Tl imaging in assessing the tumor response to anti-cancer therapy are discussed in this review. (201)Tl has distinctive advantages but more recent agents such as (99m)Tc MIBI and positron emitters have some clinical superiorities over (201)Tl in this usage.

本刊更多论文

铊-201显像评价肿瘤对抗肿瘤治疗的反应。

本文讨论了(201)Tl成像在评估肿瘤对抗癌治疗反应方面的优势和局限性。(201)Tl具有明显的优势，但最近的药物如(99m)Tc、MIBI和正电子发射器在这方面比(201)Tl具有一些临床优势。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR)

自引率

0.00%

发文量